MktsMarkets

ALX Oncology Holdings Inc.
NASDAQ: ALXOKey statistics
ALXO News
Stories mentioning ALXO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 13,606 | 17,645 | 17,441 | 18,022 | 23,888 | 23,532 | 26,471 | 34,653 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 18,966 | 23,021 | 22,532 | 26,648 | 31,820 | 30,613 | 32,567 | 41,525 |
| Operating Income (Loss) | (18,966) | (23,021) | (22,532) | (26,648) | (31,820) | (30,613) | (32,567) | (41,525) |
| Interest Income | 1,182 | 573.00 | 802.00 | 1,106 | 1,483 | 1,878 | 2,303 | 2,563 |
| Interest Expense | 331.00 | 383.00 | 408.00 | 405.00 | 406.00 | 427.00 | 446.00 | 429.00 |
| Other Expense | 188.00 | (17.00) | (6.00) | (2.00) | (11.00) | (1.00) | 3.00 | (8.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (17,927) | (22,848) | (22,144) | (25,949) | (30,754) | (29,163) | (30,707) | (39,399) |
| Earnings Per Share (Basic) | (0.17) | (0.43) | (0.41) | (0.49) | (0.58) | (0.56) | (0.58) | (0.76) |
| Earnings Per Share (Diluted) | (0.17) | (0.43) | (0.41) | (0.49) | (0.58) | (0.56) | (0.58) | (0.76) |
| Weighted Average Shares Outstanding (Basic) | 104,574 | 53,658 | 53,577 | 53,446 | 53,359 | 52,175 | 52,694 | 51,831 |
| Weighted Average Shares Outstanding (Diluted) | 104,574 | 53,658 | 53,577 | 53,446 | 53,359 | 52,175 | 52,694 | 51,831 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ALXO
ALX Oncology Holdings Inc. (NASDAQ: ALXO) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALXO. It last traded at $1.06 (Nov 20, 2026, 9:30 AM ET), up 3.9% on the day. That gives ALX Oncology a market capitalisation of $131.9M.
Over the past 52 weeks ALXO has traded between $0.8600 and $2.66.
For the quarter ended Mar 31, 2026 it reported a net loss of $17.9M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$17.9M |
| Dec 31, 2025 | — | -$22.8M |
| Sep 30, 2025 | — | -$22.1M |
| Jun 30, 2025 | — | -$25.9M |
From ALX Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…